| |
|
|
|
Kazia Therapeutics Limited  
|
|
3.15 0 (0%) |
10-12 15:56 |
|
Open: |
3.18 |
Pre close: |
3.15 |
Target:
|
4.09
|
|
High: |
3.18 |
Low: |
2.9001 |
Resistance:
|
3.50
4.09
|
|
Volume: |
3,276 |
Market Cap: |
15M |
Support:
|
3.04
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.14
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
3.12  |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
3.60 |
Stochastic Oscillator |
%K(14,3):
|
68.97 |
|
MA(250): |
4.00 |
%D(3): |
68.77 |
|
Average Volume(K) |
3-Month: |
594
|
52-Week |
High:
|
6.68 |
|
10-Days: |
402 |
Low: |
1.63 |
|
RSI |
RSI(14):
|
48.77 |
Change(%): |
3.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-20.5 |
Shares Out. (M) |
4.84 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-14.2 |
Shares Float (M) |
4.82 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-63.0 |
% Held by Institutions |
12.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
0.840 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.40 |
P/S |
330955456.00 |
|
Operating Margin |
-411.41 |
Levered Free Cash Flow
(M) |
-4.26 |
P/CF |
-2.38 |
|
|
|
|
|
|
